Blood Pressure and Outcomes in Patients With Different Etiologies of Intracerebral Hemorrhage: A Multicenter Cohort Study.
Shuting Zhang,Zhihao Wang,Aiping Zheng,Ruozhen Yuan,Yang Shu,Shihong Zhang,Peng Lei,Bo Wu,Ming Liu
DOI: https://doi.org/10.1161/jaha.120.016766
IF: 6.106
2020-09-16
Journal of the American Heart Association
Abstract:Background We aimed to investigate the association between blood pressure (BP) and outcomes in intracerebral hemorrhage (ICH) subtypes with different etiologies. Methods and Results A total of 5656 in‐hospital patients with spontaneous ICH were included between January 2012 and December 2016 in a prospective multicenter cohort study. Etiological subtypes of ICH were assigned using SMASH‐U (structural lesion, medication, amyloid angiopathy, systemic/other disease, hypertension, undetermined) classification. Elevated systolic BP was defined as ≥140 mm Hg. Hypertension was defined as elevated BP for >1 month before the onset of ICH. The primary outcomes were measured as 1‐month survival rate and 3‐month mortality. A total of 5380 patients with ICH were analyzed, of whom 4052 (75.3%) had elevated systolic BP on admission and 3015 (56.0%) had hypertension. In multinomial analysis of patients who passed away by 3 months, systolic BP on admission was significantly different in cerebral amyloid angiopathy ( P <0.001), structural lesion ( P <0.001), and undetermined subtypes ( P =0.003), compared with the hypertensive angiopathy subtype. Elevated systolic BP was dose‐responsively associated with higher 3‐month mortality in hypertensive angiopathy ( P trend =0.013) and undetermined ( P trend =0.005) subtypes. In cerebral amyloid angiopathy, hypertension history had significant inverse association with 3‐month mortality (adjusted odds ratio, 0.37, 95% CI, 0.20–0.65; P <0.001). Similarly, adjusted Cox regression indicated decreased risk of 1‐month survival rate in the presence of hypertension in patients with cerebral amyloid angiopathy (adjusted hazard ratio, 0.47; 95% CI, 0.24–0.92; P =0.027). Conclusions This study suggests that the association between BP and ICH outcomes might specifically depend on its subtypes, and cerebral amyloid angiopathy might be pathologically distinctive from the others. Future studies of individualized BP‐lowering strategy are needed to validate our findings. Nonstandard Abbreviations and Acronyms CAA cerebral amyloid angiopathy DBP diastolic blood pressure HA hypertensive angiopathy H‐ATOMIC hypertension, cerebral amyloid angiopathy, tumor, oral anticoagulants, vascular malformation, infrequent causes, and cryptogenic ICH intracerebral hemorrhage INTERACT2 Intensive BP Reduction in the Acute Cerebral Hemorrhage clinical trial SBP systolic blood pressure SMASH‐U structural lesion, medication, amyloid angiopathy, systemic/other disease, hypertension, and undetermined Clinical Perspective What Is New? The association between blood pressure and intracerebral hemorrhage outcomes might specifically depend on its subtypes and cerebral amyloid angiopathy might be pathologically distinctive from the others. Our results suggest differential contribution of blood pressure to the pathological mechanism underlying different intracerebral hemorrhage subtypes. What Are the Clinical Implications? These findings will be of significance for future research to individualize the blood pressure–lowering strategy. Intracerebral hemorrhage (ICH), a heterogeneous group of cerebrovascular diseases of different etiologies, is the least treatable form of stroke, and no specific proven therapy is available. 1 Based on a national community‐based study in China, ICH accounts for ≈25% of all cases of stroke, which is significantly higher than the 8% to 15% in Western populations. 2 , 3 One reason may be that hypertension in China is highly prevalent (28%) but poorly controlled (<20%). 4 Blood pressure (BP) control is a priority for clinicians -Abstract Truncated-
cardiac & cardiovascular systems